Abstract:Programmed cell death (PCD) is an essential part of organismal development and plays fundamental roles in host defense against pathogens and the maintenance of homeostasis. However, excess activation of PCD pathways has proven to be detrimental and can drive disease. Additionally, resistance to PCD can also contribute to disease development. Modulation of PCD, therefore, has great therapeutic potential in a wide range of diseases, including infectious, neurodegenerative, autoinflammatory, and metabolic diseases and cancer. Nevertheless, manipulation of cell death and inflammation for therapeutic intervention is a delicate process, highly specific to the context of the disease of interest, making the selection of the appropriate target molecule crucially important. Several PCD pathways are associated with innate immunity, including pyroptosis, apoptosis, necroptosis, and PANoptosis, which is defined as an inflammatory PCD pathway with key features of pyroptosis, apoptosis, and/or necroptosis that cannot be accounted for by any of these three PCD pathways alone. All of these PCD pathways are regulated by upstream sensors and signaling cascades that assemble multimeric complexes to serve as activation platforms for downstream molecules; these sensors and signaling molecules provide attractive target points for therapeutic intervention. Here, we discuss the molecular mechanisms of innate immune-mediated cell death in health and disease, with a particular focus on the molecules putatively involved in the formation of the PANoptosome and the induction of inflammatory cell death. Further, we discuss the implications and feasibility of targeting these molecules to improve disease outcomes, as well as current clinical approaches.

Role of bioactive peptides derived from food proteins in programmed cell death to treat inflammatory diseases and cancer

Programmed cell death: molecular mechanisms, biological functions, diseases, and therapeutic targets

Progress in phytochemicals′ induction of autophagic cell death in cancer cells and regulation of nuclear receptors

Anti-Inflammatory Function of Plant-Derived Bioactive Peptides: A Review

Production and Functionality of Food-derived bioactive peptides: A review.

Cell death pathways: molecular mechanisms and therapeutic targets for cancer

Dual roles of inflammatory programmed cell death in cancer: insights into pyroptosis and necroptosis

Gene Expression Regulation and the Signal Transduction of Programmed Cell Death

Programming inflammatory cell death for therapy

Programmed Cell Death Tunes Tumor Immunity

Non-apoptotic cell death in malignant tumor cells and natural compounds

The role of short-chain fatty acids in orchestrating two types of programmed cell death in colon cancer

Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment

Cell death-mediated cytokine release and its therapeutic implications

The Mechanisms of Regulated Cell Death: Structural and Functional Proteomic Pathways Induced or Inhibited by a Specific Protein-A Narrative Review

Advancements in programmed cell death research in antitumor therapy: a comprehensive overview

Role of pyroptosis in the pathogenesis and treatment of diseases

The Application of Natural Products in Cancer Therapy by Targeting Apoptosis Pathways.

Using Small Molecules to Dissect Non‐apoptotic Programmed Cell Death: Necroptosis, Ferroptosis, and Pyroptosis

Non-apoptotic cell death-based cancer therapy: Molecular mechanism, pharmacological modulators, and nanomedicine

Advances in the application and mechanism of bioactive peptides in the treatment of inflammation